nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—Ethinyl Estradiol—osteoporosis	0.0902	0.133	CbGbCtD
Fluticasone furoate—CYP3A4—Estropipate—osteoporosis	0.0839	0.124	CbGbCtD
Fluticasone furoate—CYP3A4—Calcitriol—osteoporosis	0.0839	0.124	CbGbCtD
Fluticasone furoate—CYP3A4—Ergocalciferol—osteoporosis	0.0671	0.099	CbGbCtD
Fluticasone furoate—ABCB1—Conjugated Estrogens—osteoporosis	0.0662	0.0978	CbGbCtD
Fluticasone furoate—ABCB1—Estradiol—osteoporosis	0.0581	0.0859	CbGbCtD
Fluticasone furoate—CYP3A4—Raloxifene—osteoporosis	0.056	0.0827	CbGbCtD
Fluticasone furoate—CYP3A4—Ethinyl Estradiol—osteoporosis	0.054	0.0798	CbGbCtD
Fluticasone furoate—CYP3A4—Cholecalciferol—osteoporosis	0.0432	0.0638	CbGbCtD
Fluticasone furoate—CYP3A4—Conjugated Estrogens—osteoporosis	0.0397	0.0586	CbGbCtD
Fluticasone furoate—CYP3A4—Estradiol—osteoporosis	0.0348	0.0514	CbGbCtD
Fluticasone furoate—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00207	0.114	CbGpPWpGaD
Fluticasone furoate—Migraine—Raloxifene—osteoporosis	0.00188	0.00616	CcSEcCtD
Fluticasone furoate—Migraine—Ibandronate—osteoporosis	0.00186	0.0061	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Conjugated Estrogens—osteoporosis	0.00179	0.00588	CcSEcCtD
Fluticasone furoate—Candida infection—Zoledronate—osteoporosis	0.00178	0.00583	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Ibandronate—osteoporosis	0.00169	0.00554	CcSEcCtD
Fluticasone furoate—Visual disturbance—Ethinyl Estradiol—osteoporosis	0.00168	0.00552	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Calcitriol—osteoporosis	0.00165	0.00542	CcSEcCtD
Fluticasone furoate—Bronchitis—Raloxifene—osteoporosis	0.00158	0.0052	CcSEcCtD
Fluticasone furoate—Migraine—Ethinyl Estradiol—osteoporosis	0.00157	0.00515	CcSEcCtD
Fluticasone furoate—Bronchitis—Ibandronate—osteoporosis	0.00157	0.00515	CcSEcCtD
Fluticasone furoate—Herpes simplex—Estradiol—osteoporosis	0.00156	0.0051	CcSEcCtD
Fluticasone furoate—Ulcer—Estradiol—osteoporosis	0.00152	0.00497	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Estradiol—osteoporosis	0.00143	0.0047	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Raloxifene—osteoporosis	0.00143	0.00469	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Risedronate—osteoporosis	0.00139	0.00456	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Calcitriol—osteoporosis	0.00138	0.00454	CcSEcCtD
Fluticasone furoate—Visual disturbance—Conjugated Estrogens—osteoporosis	0.00137	0.0045	CcSEcCtD
Fluticasone furoate—Candida infection—Estradiol—osteoporosis	0.00137	0.00449	CcSEcCtD
Fluticasone furoate—Pharyngitis—Estropipate—osteoporosis	0.00135	0.00443	CcSEcCtD
Fluticasone furoate—Bronchitis—Ethinyl Estradiol—osteoporosis	0.00133	0.00435	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Pamidronate—osteoporosis	0.00132	0.00434	CcSEcCtD
Fluticasone furoate—Visual impairment—Estropipate—osteoporosis	0.00131	0.00431	CcSEcCtD
Fluticasone furoate—Pharyngitis—Raloxifene—osteoporosis	0.00131	0.00429	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Raloxifene—osteoporosis	0.0013	0.00425	CcSEcCtD
Fluticasone furoate—Pharyngitis—Ibandronate—osteoporosis	0.0013	0.00425	CcSEcCtD
Fluticasone furoate—Bronchitis—Risedronate—osteoporosis	0.00129	0.00424	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Ibandronate—osteoporosis	0.00128	0.00421	CcSEcCtD
Fluticasone furoate—Migraine—Conjugated Estrogens—osteoporosis	0.00128	0.0042	CcSEcCtD
Fluticasone furoate—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00128	0.07	CbGpPWpGaD
Fluticasone furoate—Eye disorder—Estropipate—osteoporosis	0.00127	0.00417	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Calcium Acetate—osteoporosis	0.00125	0.00412	CcSEcCtD
Fluticasone furoate—Angioedema—Etidronic acid—osteoporosis	0.00125	0.00411	CcSEcCtD
Fluticasone furoate—Immune system disorder—Estropipate—osteoporosis	0.00123	0.00404	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Estropipate—osteoporosis	0.00123	0.00403	CcSEcCtD
Fluticasone furoate—Eye disorder—Ibandronate—osteoporosis	0.00122	0.004	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Zoledronate—osteoporosis	0.00121	0.00396	CcSEcCtD
Fluticasone furoate—Immune system disorder—Ibandronate—osteoporosis	0.00118	0.00387	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Ibandronate—osteoporosis	0.00118	0.00386	CcSEcCtD
Fluticasone furoate—Diarrhoea—Calcium Acetate—osteoporosis	0.00117	0.00382	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Risedronate—osteoporosis	0.00117	0.00382	CcSEcCtD
Fluticasone furoate—Back pain—Estropipate—osteoporosis	0.00115	0.00376	CcSEcCtD
Fluticasone furoate—Dizziness—Calcium Acetate—osteoporosis	0.00113	0.0037	CcSEcCtD
Fluticasone furoate—Infection—Etidronic acid—osteoporosis	0.00111	0.00364	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Pamidronate—osteoporosis	0.00111	0.00363	CcSEcCtD
Fluticasone furoate—Back pain—Ibandronate—osteoporosis	0.0011	0.00361	CcSEcCtD
Fluticasone furoate—Visual disturbance—Estradiol—osteoporosis	0.0011	0.0036	CcSEcCtD
Fluticasone furoate—Pharyngitis—Ethinyl Estradiol—osteoporosis	0.0011	0.00359	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.00108	0.00356	CcSEcCtD
Fluticasone furoate—Angioedema—Estropipate—osteoporosis	0.00108	0.00355	CcSEcCtD
Fluticasone furoate—Bronchitis—Conjugated Estrogens—osteoporosis	0.00108	0.00355	CcSEcCtD
Fluticasone furoate—Pharyngitis—Risedronate—osteoporosis	0.00107	0.0035	CcSEcCtD
Fluticasone furoate—Angioedema—Alendronate—osteoporosis	0.00107	0.0035	CcSEcCtD
Fluticasone furoate—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00106	0.00349	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Risedronate—osteoporosis	0.00106	0.00347	CcSEcCtD
Fluticasone furoate—Palpitations—Estropipate—osteoporosis	0.00105	0.00344	CcSEcCtD
Fluticasone furoate—Angioedema—Ibandronate—osteoporosis	0.00104	0.00341	CcSEcCtD
Fluticasone furoate—Cough—Estropipate—osteoporosis	0.00103	0.00339	CcSEcCtD
Fluticasone furoate—Eye disorder—Ethinyl Estradiol—osteoporosis	0.00103	0.00338	CcSEcCtD
Fluticasone furoate—Migraine—Estradiol—osteoporosis	0.00102	0.00336	CcSEcCtD
Fluticasone furoate—Agitation—Calcitriol—osteoporosis	0.00102	0.00335	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Zoledronate—osteoporosis	0.00101	0.00332	CcSEcCtD
Fluticasone furoate—Nausea—Calcium Acetate—osteoporosis	0.00101	0.00332	CcSEcCtD
Fluticasone furoate—Eye disorder—Risedronate—osteoporosis	0.00101	0.0033	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Pamidronate—osteoporosis	0.00101	0.0033	CcSEcCtD
Fluticasone furoate—Palpitations—Ibandronate—osteoporosis	0.001	0.0033	CcSEcCtD
Fluticasone furoate—Cough—Raloxifene—osteoporosis	0.001	0.00329	CcSEcCtD
Fluticasone furoate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.000997	0.0547	CbGpPWpGaD
Fluticasone furoate—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.000997	0.00327	CcSEcCtD
Fluticasone furoate—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000988	0.0542	CbGpPWpGaD
Fluticasone furoate—Immune system disorder—Risedronate—osteoporosis	0.000972	0.00319	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Risedronate—osteoporosis	0.00097	0.00318	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Estropipate—osteoporosis	0.000967	0.00317	CcSEcCtD
Fluticasone furoate—Infection—Estropipate—osteoporosis	0.000961	0.00315	CcSEcCtD
Fluticasone furoate—Eye disorder—Pamidronate—osteoporosis	0.000956	0.00314	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Estropipate—osteoporosis	0.000949	0.00311	CcSEcCtD
Fluticasone furoate—Infection—Alendronate—osteoporosis	0.000946	0.00311	CcSEcCtD
Fluticasone furoate—Infection—Raloxifene—osteoporosis	0.000931	0.00305	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Estradiol—osteoporosis	0.000931	0.00305	CcSEcCtD
Fluticasone furoate—Back pain—Ethinyl Estradiol—osteoporosis	0.000929	0.00305	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Ibandronate—osteoporosis	0.000928	0.00304	CcSEcCtD
Fluticasone furoate—Immune system disorder—Pamidronate—osteoporosis	0.000924	0.00303	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Pamidronate—osteoporosis	0.000922	0.00302	CcSEcCtD
Fluticasone furoate—Infection—Ibandronate—osteoporosis	0.000921	0.00302	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Raloxifene—osteoporosis	0.000919	0.00302	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Zoledronate—osteoporosis	0.000918	0.00301	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Ibandronate—osteoporosis	0.00091	0.00298	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Calcitriol—osteoporosis	0.000908	0.00298	CcSEcCtD
Fluticasone furoate—Back pain—Risedronate—osteoporosis	0.000906	0.00297	CcSEcCtD
Fluticasone furoate—Nausea—Ergocalciferol—osteoporosis	0.000894	0.00293	CcSEcCtD
Fluticasone furoate—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000893	0.00293	CcSEcCtD
Fluticasone furoate—Urticaria—Etidronic acid—osteoporosis	0.000888	0.00291	CcSEcCtD
Fluticasone furoate—Angioedema—Ethinyl Estradiol—osteoporosis	0.000878	0.00288	CcSEcCtD
Fluticasone furoate—Eye disorder—Zoledronate—osteoporosis	0.000873	0.00286	CcSEcCtD
Fluticasone furoate—Visual impairment—Conjugated Estrogens—osteoporosis	0.000867	0.00284	CcSEcCtD
Fluticasone furoate—Bronchitis—Estradiol—osteoporosis	0.000865	0.00284	CcSEcCtD
Fluticasone furoate—Back pain—Pamidronate—osteoporosis	0.000861	0.00283	CcSEcCtD
Fluticasone furoate—Angioedema—Risedronate—osteoporosis	0.000856	0.00281	CcSEcCtD
Fluticasone furoate—Immune system disorder—Zoledronate—osteoporosis	0.000844	0.00277	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Zoledronate—osteoporosis	0.000842	0.00276	CcSEcCtD
Fluticasone furoate—Eye disorder—Conjugated Estrogens—osteoporosis	0.000841	0.00276	CcSEcCtD
Fluticasone furoate—Cough—Ethinyl Estradiol—osteoporosis	0.000838	0.00275	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Etidronic acid—osteoporosis	0.000824	0.0027	CcSEcCtD
Fluticasone furoate—Agitation—Pamidronate—osteoporosis	0.000818	0.00268	CcSEcCtD
Fluticasone furoate—Cough—Risedronate—osteoporosis	0.000817	0.00268	CcSEcCtD
Fluticasone furoate—Angioedema—Pamidronate—osteoporosis	0.000814	0.00267	CcSEcCtD
Fluticasone furoate—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000813	0.00267	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000811	0.00266	CcSEcCtD
Fluticasone furoate—Back pain—Zoledronate—osteoporosis	0.000787	0.00258	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Estradiol—osteoporosis	0.00078	0.00256	CcSEcCtD
Fluticasone furoate—Infection—Ethinyl Estradiol—osteoporosis	0.000779	0.00256	CcSEcCtD
Fluticasone furoate—Cough—Pamidronate—osteoporosis	0.000777	0.00255	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000769	0.00252	CcSEcCtD
Fluticasone furoate—Urticaria—Estropipate—osteoporosis	0.000768	0.00252	CcSEcCtD
Fluticasone furoate—Diarrhoea—Etidronic acid—osteoporosis	0.000765	0.00251	CcSEcCtD
Fluticasone furoate—Body temperature increased—Estropipate—osteoporosis	0.000765	0.00251	CcSEcCtD
Fluticasone furoate—Tremor—Zoledronate—osteoporosis	0.000762	0.0025	CcSEcCtD
Fluticasone furoate—Infection—Risedronate—osteoporosis	0.000759	0.00249	CcSEcCtD
Fluticasone furoate—Back pain—Conjugated Estrogens—osteoporosis	0.000758	0.00249	CcSEcCtD
Fluticasone furoate—Urticaria—Alendronate—osteoporosis	0.000757	0.00248	CcSEcCtD
Fluticasone furoate—Epistaxis—Estradiol—osteoporosis	0.000756	0.00248	CcSEcCtD
Fluticasone furoate—Body temperature increased—Alendronate—osteoporosis	0.000753	0.00247	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Risedronate—osteoporosis	0.00075	0.00246	CcSEcCtD
Fluticasone furoate—Agitation—Zoledronate—osteoporosis	0.000747	0.00245	CcSEcCtD
Fluticasone furoate—Angioedema—Zoledronate—osteoporosis	0.000743	0.00244	CcSEcCtD
Fluticasone furoate—Body temperature increased—Raloxifene—osteoporosis	0.000741	0.00243	CcSEcCtD
Fluticasone furoate—Urticaria—Ibandronate—osteoporosis	0.000737	0.00242	CcSEcCtD
Fluticasone furoate—Body temperature increased—Ibandronate—osteoporosis	0.000733	0.00241	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Pamidronate—osteoporosis	0.000727	0.00238	CcSEcCtD
Fluticasone furoate—Infection—Pamidronate—osteoporosis	0.000722	0.00237	CcSEcCtD
Fluticasone furoate—Urticaria—Calcitriol—osteoporosis	0.000721	0.00237	CcSEcCtD
Fluticasone furoate—Palpitations—Zoledronate—osteoporosis	0.000719	0.00236	CcSEcCtD
Fluticasone furoate—Body temperature increased—Calcitriol—osteoporosis	0.000718	0.00236	CcSEcCtD
Fluticasone furoate—Angioedema—Conjugated Estrogens—osteoporosis	0.000716	0.00235	CcSEcCtD
Fluticasone furoate—Pharyngitis—Estradiol—osteoporosis	0.000715	0.00234	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Estropipate—osteoporosis	0.000713	0.00234	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Pamidronate—osteoporosis	0.000713	0.00234	CcSEcCtD
Fluticasone furoate—Cough—Zoledronate—osteoporosis	0.00071	0.00233	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Estradiol—osteoporosis	0.000708	0.00232	CcSEcCtD
Fluticasone furoate—Rash—Etidronic acid—osteoporosis	0.000705	0.00231	CcSEcCtD
Fluticasone furoate—Dermatitis—Etidronic acid—osteoporosis	0.000704	0.00231	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Alendronate—osteoporosis	0.000702	0.0023	CcSEcCtD
Fluticasone furoate—Headache—Etidronic acid—osteoporosis	0.0007	0.0023	CcSEcCtD
Fluticasone furoate—Visual impairment—Estradiol—osteoporosis	0.000694	0.00228	CcSEcCtD
Fluticasone furoate—Palpitations—Conjugated Estrogens—osteoporosis	0.000692	0.00227	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Ibandronate—osteoporosis	0.000683	0.00224	CcSEcCtD
Fluticasone furoate—Cough—Conjugated Estrogens—osteoporosis	0.000683	0.00224	CcSEcCtD
Fluticasone furoate—Dyspnoea—Risedronate—osteoporosis	0.000682	0.00224	CcSEcCtD
Fluticasone furoate—Eye disorder—Estradiol—osteoporosis	0.000673	0.00221	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Calcitriol—osteoporosis	0.000669	0.0022	CcSEcCtD
Fluticasone furoate—Nausea—Etidronic acid—osteoporosis	0.000664	0.00218	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Zoledronate—osteoporosis	0.000664	0.00218	CcSEcCtD
Fluticasone furoate—Diarrhoea—Estropipate—osteoporosis	0.000662	0.00217	CcSEcCtD
Fluticasone furoate—Infection—Zoledronate—osteoporosis	0.000659	0.00216	CcSEcCtD
Fluticasone furoate—Diarrhoea—Alendronate—osteoporosis	0.000652	0.00214	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Zoledronate—osteoporosis	0.000651	0.00214	CcSEcCtD
Fluticasone furoate—Immune system disorder—Estradiol—osteoporosis	0.00065	0.00213	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Estradiol—osteoporosis	0.000649	0.00213	CcSEcCtD
Fluticasone furoate—Dyspnoea—Pamidronate—osteoporosis	0.000648	0.00213	CcSEcCtD
Fluticasone furoate—Diarrhoea—Raloxifene—osteoporosis	0.000641	0.0021	CcSEcCtD
Fluticasone furoate—Dizziness—Estropipate—osteoporosis	0.00064	0.0021	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000639	0.0021	CcSEcCtD
Fluticasone furoate—Infection—Conjugated Estrogens—osteoporosis	0.000635	0.00208	CcSEcCtD
Fluticasone furoate—Diarrhoea—Ibandronate—osteoporosis	0.000635	0.00208	CcSEcCtD
Fluticasone furoate—Dizziness—Alendronate—osteoporosis	0.00063	0.00207	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000627	0.00206	CcSEcCtD
Fluticasone furoate—Urticaria—Ethinyl Estradiol—osteoporosis	0.000623	0.00204	CcSEcCtD
Fluticasone furoate—Diarrhoea—Calcitriol—osteoporosis	0.000621	0.00204	CcSEcCtD
Fluticasone furoate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00062	0.00203	CcSEcCtD
Fluticasone furoate—Dizziness—Raloxifene—osteoporosis	0.00062	0.00203	CcSEcCtD
Fluticasone furoate—Dizziness—Ibandronate—osteoporosis	0.000613	0.00201	CcSEcCtD
Fluticasone furoate—Rash—Estropipate—osteoporosis	0.00061	0.002	CcSEcCtD
Fluticasone furoate—Dermatitis—Estropipate—osteoporosis	0.000609	0.002	CcSEcCtD
Fluticasone furoate—Urticaria—Risedronate—osteoporosis	0.000607	0.00199	CcSEcCtD
Fluticasone furoate—Back pain—Estradiol—osteoporosis	0.000606	0.00199	CcSEcCtD
Fluticasone furoate—Headache—Estropipate—osteoporosis	0.000606	0.00199	CcSEcCtD
Fluticasone furoate—Body temperature increased—Risedronate—osteoporosis	0.000604	0.00198	CcSEcCtD
Fluticasone furoate—Rash—Alendronate—osteoporosis	0.000601	0.00197	CcSEcCtD
Fluticasone furoate—Dermatitis—Alendronate—osteoporosis	0.0006	0.00197	CcSEcCtD
Fluticasone furoate—Headache—Alendronate—osteoporosis	0.000597	0.00196	CcSEcCtD
Fluticasone furoate—Dyspnoea—Zoledronate—osteoporosis	0.000592	0.00194	CcSEcCtD
Fluticasone furoate—Rash—Raloxifene—osteoporosis	0.000591	0.00194	CcSEcCtD
Fluticasone furoate—Dermatitis—Raloxifene—osteoporosis	0.00059	0.00194	CcSEcCtD
Fluticasone furoate—Tremor—Estradiol—osteoporosis	0.000587	0.00193	CcSEcCtD
Fluticasone furoate—Headache—Raloxifene—osteoporosis	0.000587	0.00193	CcSEcCtD
Fluticasone furoate—Rash—Ibandronate—osteoporosis	0.000585	0.00192	CcSEcCtD
Fluticasone furoate—Dermatitis—Ibandronate—osteoporosis	0.000584	0.00192	CcSEcCtD
Fluticasone furoate—Headache—Ibandronate—osteoporosis	0.000581	0.00191	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000578	0.0019	CcSEcCtD
Fluticasone furoate—Agitation—Estradiol—osteoporosis	0.000576	0.00189	CcSEcCtD
Fluticasone furoate—Nausea—Estropipate—osteoporosis	0.000575	0.00189	CcSEcCtD
Fluticasone furoate—Body temperature increased—Pamidronate—osteoporosis	0.000574	0.00188	CcSEcCtD
Fluticasone furoate—Angioedema—Estradiol—osteoporosis	0.000573	0.00188	CcSEcCtD
Fluticasone furoate—Rash—Calcitriol—osteoporosis	0.000573	0.00188	CcSEcCtD
Fluticasone furoate—Dermatitis—Calcitriol—osteoporosis	0.000572	0.00188	CcSEcCtD
Fluticasone furoate—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00057	0.00187	CcSEcCtD
Fluticasone furoate—Headache—Calcitriol—osteoporosis	0.000569	0.00187	CcSEcCtD
Fluticasone furoate—Nausea—Alendronate—osteoporosis	0.000566	0.00186	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Risedronate—osteoporosis	0.000563	0.00185	CcSEcCtD
Fluticasone furoate—Nausea—Raloxifene—osteoporosis	0.000557	0.00183	CcSEcCtD
Fluticasone furoate—Palpitations—Estradiol—osteoporosis	0.000554	0.00182	CcSEcCtD
Fluticasone furoate—Nausea—Ibandronate—osteoporosis	0.000551	0.00181	CcSEcCtD
Fluticasone furoate—Cough—Estradiol—osteoporosis	0.000547	0.00179	CcSEcCtD
Fluticasone furoate—Nausea—Calcitriol—osteoporosis	0.000539	0.00177	CcSEcCtD
Fluticasone furoate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000536	0.00176	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Pamidronate—osteoporosis	0.000535	0.00176	CcSEcCtD
Fluticasone furoate—Urticaria—Zoledronate—osteoporosis	0.000527	0.00173	CcSEcCtD
Fluticasone furoate—Body temperature increased—Zoledronate—osteoporosis	0.000525	0.00172	CcSEcCtD
Fluticasone furoate—Diarrhoea—Risedronate—osteoporosis	0.000523	0.00172	CcSEcCtD
Fluticasone furoate—Dizziness—Ethinyl Estradiol—osteoporosis	0.000518	0.0017	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Estradiol—osteoporosis	0.000512	0.00168	CcSEcCtD
Fluticasone furoate—Infection—Estradiol—osteoporosis	0.000508	0.00167	CcSEcCtD
Fluticasone furoate—Urticaria—Conjugated Estrogens—osteoporosis	0.000508	0.00167	CcSEcCtD
Fluticasone furoate—Dizziness—Risedronate—osteoporosis	0.000505	0.00166	CcSEcCtD
Fluticasone furoate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000505	0.00166	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Estradiol—osteoporosis	0.000502	0.00165	CcSEcCtD
Fluticasone furoate—Diarrhoea—Pamidronate—osteoporosis	0.000497	0.00163	CcSEcCtD
Fluticasone furoate—Rash—Ethinyl Estradiol—osteoporosis	0.000494	0.00162	CcSEcCtD
Fluticasone furoate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000494	0.00162	CcSEcCtD
Fluticasone furoate—Headache—Ethinyl Estradiol—osteoporosis	0.000491	0.00161	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Zoledronate—osteoporosis	0.000489	0.0016	CcSEcCtD
Fluticasone furoate—Rash—Risedronate—osteoporosis	0.000482	0.00158	CcSEcCtD
Fluticasone furoate—Dermatitis—Risedronate—osteoporosis	0.000482	0.00158	CcSEcCtD
Fluticasone furoate—Dizziness—Pamidronate—osteoporosis	0.000481	0.00158	CcSEcCtD
Fluticasone furoate—Headache—Risedronate—osteoporosis	0.000479	0.00157	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000471	0.00155	CcSEcCtD
Fluticasone furoate—Nausea—Ethinyl Estradiol—osteoporosis	0.000466	0.00153	CcSEcCtD
Fluticasone furoate—Rash—Pamidronate—osteoporosis	0.000458	0.0015	CcSEcCtD
Fluticasone furoate—Dermatitis—Pamidronate—osteoporosis	0.000458	0.0015	CcSEcCtD
Fluticasone furoate—Dyspnoea—Estradiol—osteoporosis	0.000456	0.0015	CcSEcCtD
Fluticasone furoate—Headache—Pamidronate—osteoporosis	0.000455	0.00149	CcSEcCtD
Fluticasone furoate—Diarrhoea—Zoledronate—osteoporosis	0.000454	0.00149	CcSEcCtD
Fluticasone furoate—Nausea—Risedronate—osteoporosis	0.000454	0.00149	CcSEcCtD
Fluticasone furoate—Dizziness—Zoledronate—osteoporosis	0.000439	0.00144	CcSEcCtD
Fluticasone furoate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000437	0.00143	CcSEcCtD
Fluticasone furoate—Nausea—Pamidronate—osteoporosis	0.000432	0.00142	CcSEcCtD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000424	0.0232	CbGpPWpGaD
Fluticasone furoate—Dizziness—Conjugated Estrogens—osteoporosis	0.000423	0.00139	CcSEcCtD
Fluticasone furoate—Rash—Zoledronate—osteoporosis	0.000419	0.00137	CcSEcCtD
Fluticasone furoate—Dermatitis—Zoledronate—osteoporosis	0.000418	0.00137	CcSEcCtD
Fluticasone furoate—Headache—Zoledronate—osteoporosis	0.000416	0.00136	CcSEcCtD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.00041	0.0225	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000407	0.0224	CbGpPWpGaD
Fluticasone furoate—Urticaria—Estradiol—osteoporosis	0.000406	0.00133	CcSEcCtD
Fluticasone furoate—Body temperature increased—Estradiol—osteoporosis	0.000404	0.00133	CcSEcCtD
Fluticasone furoate—Rash—Conjugated Estrogens—osteoporosis	0.000403	0.00132	CcSEcCtD
Fluticasone furoate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000403	0.00132	CcSEcCtD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000401	0.022	CbGpPWpGaD
Fluticasone furoate—Headache—Conjugated Estrogens—osteoporosis	0.0004	0.00131	CcSEcCtD
Fluticasone furoate—Nausea—Zoledronate—osteoporosis	0.000394	0.00129	CcSEcCtD
Fluticasone furoate—Nausea—Conjugated Estrogens—osteoporosis	0.00038	0.00125	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Estradiol—osteoporosis	0.000377	0.00124	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.000361	0.0198	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000358	0.0196	CbGpPWpGaD
Fluticasone furoate—Diarrhoea—Estradiol—osteoporosis	0.00035	0.00115	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.000348	0.0191	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000343	0.0188	CbGpPWpGaD
Fluticasone furoate—Dizziness—Estradiol—osteoporosis	0.000338	0.00111	CcSEcCtD
Fluticasone furoate—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000331	0.0181	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.000323	0.0177	CbGpPWpGaD
Fluticasone furoate—Rash—Estradiol—osteoporosis	0.000323	0.00106	CcSEcCtD
Fluticasone furoate—Dermatitis—Estradiol—osteoporosis	0.000322	0.00106	CcSEcCtD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000322	0.0177	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000321	0.0176	CbGpPWpGaD
Fluticasone furoate—Headache—Estradiol—osteoporosis	0.00032	0.00105	CcSEcCtD
Fluticasone furoate—Nausea—Estradiol—osteoporosis	0.000304	0.000997	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.000303	0.0166	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.000302	0.0166	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000296	0.0162	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.000275	0.0151	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000256	0.014	CbGpPWpGaD
Fluticasone furoate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.000247	0.0136	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.000247	0.0136	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000204	0.0112	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—WNT1—osteoporosis	0.0002	0.0109	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000195	0.0107	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00019	0.0104	CbGpPWpGaD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00019	0.0104	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.000185	0.0102	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—BMP2—osteoporosis	0.00018	0.0099	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000177	0.00969	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000162	0.00888	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.00016	0.00877	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00016	0.00876	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000152	0.00836	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	0.000152	0.00832	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.00015	0.00821	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000135	0.0074	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000132	0.00722	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000131	0.0072	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.00012	0.00659	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000117	0.00642	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000105	0.00577	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IRS2—osteoporosis	9.89e-05	0.00543	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—LEP—osteoporosis	9.68e-05	0.00531	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	8.94e-05	0.00491	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IRS1—osteoporosis	8.63e-05	0.00474	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.5e-05	0.00466	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	8.45e-05	0.00464	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.39e-05	0.0046	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	8.05e-05	0.00442	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IGF1—osteoporosis	8e-05	0.00439	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	7.88e-05	0.00433	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	7.87e-05	0.00432	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	7.02e-05	0.00385	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	7.01e-05	0.00385	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—U2AF1—osteoporosis	6.99e-05	0.00383	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	6.97e-05	0.00382	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.89e-05	0.00378	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	6.87e-05	0.00377	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	6.02e-05	0.0033	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	5.93e-05	0.00325	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	5.63e-05	0.00309	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	5.56e-05	0.00305	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	5.33e-05	0.00293	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	5.22e-05	0.00287	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—RPL24—osteoporosis	5.19e-05	0.00285	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.11e-05	0.0028	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL1B—osteoporosis	4.94e-05	0.00271	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TGFB1—osteoporosis	4.79e-05	0.00263	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.72e-05	0.00259	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TNF—osteoporosis	4.48e-05	0.00246	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	4.41e-05	0.00242	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.14e-05	0.00227	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	3.87e-05	0.00212	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.84e-05	0.0021	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.66e-05	0.00201	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.65e-05	0.002	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IL6—osteoporosis	3.61e-05	0.00198	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.61e-05	0.00198	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TNF—osteoporosis	3.58e-05	0.00197	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	3.37e-05	0.00185	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PKM—osteoporosis	3.37e-05	0.00185	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—FDPS—osteoporosis	3.37e-05	0.00185	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PGLS—osteoporosis	3.19e-05	0.00175	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GPD2—osteoporosis	3.19e-05	0.00175	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.16e-05	0.00173	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	3.12e-05	0.00171	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PSMA5—osteoporosis	3e-05	0.00164	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PSMA2—osteoporosis	3e-05	0.00164	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PNP—osteoporosis	2.92e-05	0.0016	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ATIC—osteoporosis	2.92e-05	0.0016	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ESR2—osteoporosis	2.68e-05	0.00147	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—OXCT1—osteoporosis	2.48e-05	0.00136	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CA2—osteoporosis	2.48e-05	0.00136	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—MGLL—osteoporosis	2.42e-05	0.00133	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—POMC—osteoporosis	2.2e-05	0.00121	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—VDR—osteoporosis	2.13e-05	0.00117	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PKM—osteoporosis	2.07e-05	0.00114	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—FDPS—osteoporosis	2.07e-05	0.00114	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—IDH2—osteoporosis	2.06e-05	0.00113	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PGLS—osteoporosis	1.97e-05	0.00108	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GPD2—osteoporosis	1.97e-05	0.00108	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP27A1—osteoporosis	1.93e-05	0.00106	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.9e-05	0.00104	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.89e-05	0.00104	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ACP5—osteoporosis	1.88e-05	0.00103	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PNP—osteoporosis	1.8e-05	0.000987	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ATIC—osteoporosis	1.8e-05	0.000987	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.77e-05	0.000972	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.77e-05	0.00097	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	1.75e-05	0.000963	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—TPI1—osteoporosis	1.75e-05	0.00096	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—P4HB—osteoporosis	1.64e-05	0.000902	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ESR1—osteoporosis	1.62e-05	0.000891	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GAPDH—osteoporosis	1.61e-05	0.000886	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—RAP1A—osteoporosis	1.57e-05	0.000862	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CA2—osteoporosis	1.53e-05	0.000839	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—OXCT1—osteoporosis	1.53e-05	0.000839	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—MGLL—osteoporosis	1.49e-05	0.000818	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ENO1—osteoporosis	1.27e-05	0.000697	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—IDH2—osteoporosis	1.27e-05	0.000695	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PSMA2—osteoporosis	1.25e-05	0.000687	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PSMA5—osteoporosis	1.25e-05	0.000687	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.19e-05	0.000654	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ACP5—osteoporosis	1.16e-05	0.000636	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—TPI1—osteoporosis	1.08e-05	0.000591	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP19A1—osteoporosis	1.02e-05	0.000557	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—P4HB—osteoporosis	1.01e-05	0.000556	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GAPDH—osteoporosis	9.94e-06	0.000546	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—RAP1A—osteoporosis	9.68e-06	0.000531	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MYC—osteoporosis	8.45e-06	0.000464	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ADCY5—osteoporosis	8.3e-06	0.000455	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GPX1—osteoporosis	8.27e-06	0.000454	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ENO1—osteoporosis	7.83e-06	0.00043	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PSMA5—osteoporosis	7.71e-06	0.000423	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PSMA2—osteoporosis	7.71e-06	0.000423	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—MTHFR—osteoporosis	7.63e-06	0.000419	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.26e-06	0.000343	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—POMC—osteoporosis	6.1e-06	0.000335	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ADCY5—osteoporosis	5.11e-06	0.000281	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GPX1—osteoporosis	5.1e-06	0.00028	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—MTHFR—osteoporosis	4.7e-06	0.000258	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—POMC—osteoporosis	3.76e-06	0.000206	CbGpPWpGaD
